A prospective cohort study to search for a risk factor of chemotherapy induced nausea and vomiting in patients with colorectal cancer.

ABSTRACT: Primary outcome(s): Complete response rate during 24 to 120 hours (delay phase) after an anticancer agent dosage start

DISEASE(S): Colorectal Cancer

PROVIDER: 2625556 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR